The EANM and Springer are bestowing the EJNMMI Awards during the EANM Annual Congress for outstanding publications across the whole journal family.
The European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI) is the official journal of the EANM, dedicated to the exchange of clinical and scientific information for the nuclear medicine community and allied professions involved in the functional, metabolic and molecular investigation of disease.
The EJNMMI journal family was constantly expanded over the last years and now also features dedicated publications for the areas of basic, translational and clinical research (EJNMMI Research), the development of new imaging and radionuclide based therapeutic agents (EJNMMI Radiopharmacy and Chemistry), applied physics, mathematics and imaging systems engineering/prototyping (EJNMMI Physics) as well as clinical research conducted with hybrid or multimodality imaging techniques (European Journal of Hybrid Imaging – The EJNMMI Multimodality Journal).
Up to now, the following journals are bestowing awards:
- EJNMMI Research
- EJNMMI Physics
- EJNMMI Radiopharmacy and Chemistry (as of 2017)
Based on the number of citations, number of downloads or the quality of the publication, the following awards are issued (multiple awards per journal possible):
- Most Cited Paper
- Most Downloaded Paper
- Best Paper – Editor’s Choice
The winners will be notified by Springer during the summer months preceding the EANM congress. As a special sign of recognition, the winner will receive free access to the EANM Congress, during which the award is bestowed and will receive up to EUR 1,000 contribution to the travel expenses by Springer.
The Award is supported by Springer